Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| 1 |
SMBS
Schwab Mortgage-Backed Securities ETF
SMBS
|
+$5.15B |
| 2 |
Schwab Municipal Bond ETF
SCMB
|
+$1.3B |
| 3 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$831M |
| 4 |
Microsoft
MSFT
|
+$763M |
| 5 |
NVIDIA
NVDA
|
+$665M |
Top Sells
Sector Composition
| 1 | Technology | 24.59% |
| 2 | Financials | 11.81% |
| 3 | Healthcare | 9.32% |
| 4 | Consumer Discretionary | 9.25% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLPR
3401
Clipper Realty
CLPR
$71.4M
| $140K | ﹤0.01% |
38,207
| – | – |
|
|
BRDG
3402
DELISTED
Bridge Investment Group
BRDG
| $140K | ﹤0.01% |
13,968
+560
| +4% | +$5.61K |
|
3403
Rhinebeck Bancorp
RBKB
$147M
| $133K | ﹤0.01% |
+11,327
| New | +$133K |
|
3404
Applied Therapeutics
APLT
$63.4M
| $126K | ﹤0.01% |
403,514
-229,015
| -36% | -$71.2K |
|
3405
Soho House & Co
SHCO
$1.73B
| $124K | ﹤0.01% |
16,810
| – | – |
|
3406
Envela
ELA
$198M
| $122K | ﹤0.01% |
+20,011
| New | +$122K |
|
|
NXXT
3407
NextNRG, Inc. Common Stock
NXXT
$221M
| $121K | ﹤0.01% |
+43,775
| New | +$121K |
|
3408
INmune Bio
INMB
$48.1M
| $120K | ﹤0.01% |
51,825
+10,505
| +25% | +$24.3K |
|
3409
Ispire Technology
ISPR
$177M
| $119K | ﹤0.01% |
46,552
+49
| +0.1% | +$125 |
|
3410
Sagimet Biosciences
SGMT
$229M
| $114K | ﹤0.01% |
15,000
| – | – |
|
3411
Unusual Machines
UMAC
$312M
| $107K | ﹤0.01% |
+12,500
| New | +$107K |
|
3412
LanzaTech
LNZA
$44.4M
| $106K | ﹤0.01% |
3,911
-2,621
| -40% | -$71.1K |
|
3413
Golden Matrix Group
GMGI
$142M
| $106K | ﹤0.01% |
62,345
+7,047
| +13% | +$12K |
|
3414
374Water
SCWO
$61.4M
| $104K | ﹤0.01% |
322,221
-141,408
| -31% | -$45.9K |
|
|
CTNM
3415
Contineum Therapeutics
CTNM
$322M
| $103K | ﹤0.01% |
26,039
-25,163
| -49% | -$99.9K |
|
|
IGMS
3416
DELISTED
IGM Biosciences
IGMS
| $100K | ﹤0.01% |
89,705
-35,909
| -29% | -$40.2K |
|
3417
Tevogen Bio Holdings
TVGN
$173M
| $95.6K | ﹤0.01% |
76,475
+26,831
| +54% | +$33.5K |
|
3418
MediciNova
MNOV
$61.8M
| $93.7K | ﹤0.01% |
71,506
| – | – |
|
3419
Century Therapeutics
IPSC
$44.1M
| $91.3K | ﹤0.01% |
163,377
-107,443
| -40% | -$60K |
|
3420
Forafric Global
AFRI
$222M
| $91.3K | ﹤0.01% |
11,701
| – | – |
|
|
ACTU
3421
Actuate Therapeutics, Inc. Common stock
ACTU
$165M
| $90.2K | ﹤0.01% |
+14,765
| New | +$90.2K |
|
3422
Spero Therapeutics
SPRO
$112M
| $82.8K | ﹤0.01% |
28,565
| – | – |
|
3423
RAPT Therapeutics
RAPT
$220M
| $80K | ﹤0.01% |
10,000
-8,868
| -47% | -$70.9K |
|
3424
Cabaletta Bio
CABA
$154M
| $76.9K | ﹤0.01% |
50,621
-109,245
| -68% | -$166K |
|
3425
Ring Energy
REI
$207M
| $76.7K | ﹤0.01% |
96,575
-367,455
| -79% | -$292K |
|